January 20, 2022Open Access

Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period

Key Points

Key points are not available for this paper at this time.

Abstract

This study examines breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in March-August 2021, when the Delta variant predominated, among a general US cohort vaccinated with mRNA-1273 or BNT162b2.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Lindsey Wang

Case Western Reserve University

Pamela B. Davis

University School

David C. Kaelber

Preventive Cardiology

Journals

JAMA

Actions

Institutions

National Institutes of Health

Case Western Reserve University

University School

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study